Phyllis is an experienced bio/pharmaceutical industry and managed care leader, who draws on her deep commercial and clinical experience to provide insights and solutions across many aspect of commercialization. Her areas of expertise include market access, channel strategy, contracting strategy and development as well as the management of orphan drugs. Phyllis’ PharmD background brings a true insider perspective to Blue Fin Group.
With more than 30 years of experience in the healthcare industry, Phyllis can apply her industry and payer knowledge to develop a tailored solution for each client. Additionally, her unique combination of clinical and business perspective allows her to drive toward practical solutions for complex and challenging problems.
Recent Finsights Blog Posts
- Real Life Chutes and Ladders: The Reality of Co-Pay Accumulators
- PCMA Annual Meeting Conference Overview
- Attending AMCP’s Annual Meeting in Denver, CO
- Orphan and Rare Disease Products and Exclusive Pharmacy Networks